Project Grant HT94252510658
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
The Defense Health Agency awarded Emory University a $1,483,611 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "ELECTRIG: EVALUATING EFFECTS OF CRANIAL ELECTRICAL STIMULATON THERAPY WITH RESPONSIVE IMAGING IN GULF WAR ILLNESS PAIN AND COMORBID SYMPTOMS", will support advanced biomedical research to investigate innovative treatments for Gulf War Illness, a condition affecting military service members. The 4-year project,...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $5,620,000.00 to Emory University to conduct MDMA-assisted massed exposure therapy for PTSD. The project will run from September 1, 2025 to August 31, 2029. As a leading research university and major recipient of federal funding, Emory University has a demonstrated track record of expertise in advanced medical research across diverse domains, including...
The Defense Health Agency awarded Emory University a $305,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a novel therapeutic target for renal medullary carcinoma. The award period runs from July 1, 2023 to June 30, 2026. As a leading research university, Emory has a strong track record of delivering scientific research and public health services under federal grants and contracts. This award supports Emory's expertise in...
The Defense Health Agency awarded Emory University a $160,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2023 through March 31, 2025. The grant will support GENOME-WIDE ANALYSES OF PROTEIN-DNA INTERACTION USING LONG-READ SEQUENCING. Through this funding, Emory University will conduct research using long-read sequencing to analyze protein-DNA interactions on a genome-wide scale. The Military Medical Research and Development...
The Defense Health Agency awarded Emory University a $156,500 project grant under the Military Medical Research and Development program to support research on core transcription factors in regenerative medicine and cancer. The one-year award beginning September 30, 2023 will fund investigation into medical solutions for the battlefield by transforming healthcare through innovative biomedical research. Specifically, Emory University will conduct research on core transcription factors as they...
Emory University was awarded a $159,929 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund whole-genome structural variation and CpG methylation analyses through long-read sequencing from April 1, 2023 to March 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical...
This $250,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program will support research at Emory University to investigate the role of neuronal activity in the behavior of oligodendrocyte progenitor cells (OPCs) and their ability to remyelinate the human spinal cord. The two-year project aims to advance the understanding of mechanisms underlying remyelination, which is critical for restoring neurological...
Emory University will conduct research under a $1,255,611 Project Grant from the Defense Health Agency through the Military Medical Research and Development program. The three-year award beginning in April 2023 will fund research to define the molecular basis for immunogenicity of locally advanced prostate tumors resistant to androgen deprivation therapy. The CFDA 12.420 program supports basic, applied and advanced biomedical research to transform military and public health care through...
Emory University was awarded a $3.13 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The four-year award will support research to elucidate mechanisms of hypertension risk in post-traumatic stress disorder. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for the battlefield. Findings from...
Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...